|
1
|
Baderca F, Cojocaru S, Lazăr E, Lăzureanu
C, Lighezan R, Alexa A, Raica M and Nicola T: Amelanotic vulvar
melanoma: Case report and review of the literature. Rom J Morphol
Embryol. 49:219–228. 2008.PubMed/NCBI
|
|
2
|
Baderca F, Vincze D, Balica N and Solovan
C: Mucosal melanomas in the elderly: Challenging cases and review
of the literature. Clin Interv Aging. 9:929–937. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuzu OF, Nguyen FD, Noory MA and Sharma A:
Current State of Animal (Mouse) Modeling in Melanoma Research.
Cancer Growth Metastasis. 8 Suppl 1:81–94. 2015.PubMed/NCBI
|
|
4
|
Potrony M, Badenas C, Aguilera P,
Puig-Butille JA, Carrera C, Malvehy J and Puig S: Update in genetic
susceptibility in melanoma. Ann Transl Med. 3:2102015.PubMed/NCBI
|
|
5
|
Delyon J, Varna M, Feugeas JP, Sadoux A,
Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Janin A,
et al: Validation of a preclinical model for assessment of drug
efficacy in melanoma. Oncotarget. 7:13069–13081. 2016.PubMed/NCBI
|
|
6
|
Candido S, Rapisarda V, Marconi A,
Malaponte G, Bevelacqua V, Gangemi P, Scalisi A, McCubrey JA,
Maestro R, Spandidos DA, et al: Analysis of the B-RafV600E mutation
in cutaneous melanoma patients with occupational sun exposure.
Oncol Rep. 31:1079–1082. 2014.PubMed/NCBI
|
|
7
|
Palmieri G, Colombino M, Sini MC, Ascierto
PA, Lissia A and Cossu A: Targeted Therapies in Melanoma: Successes
and PitfallsMelanoma-From Early Detection to Treatment. Duc GHT:
InTech Open, Reykjavik. pp. 29–58. 2013
|
|
8
|
Sun C, Wang L, Huang S, Heynen GJ,
Prahallad A, Robert C, Haanen J, Blank C, Wesseling J, Willems SM,
et al: Reversible and adaptive resistance to BRAF(V600E) inhibition
in melanoma. Nature. 508:118–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Russo A, Ficili B, Candido S, Pezzino FM,
Guarneri C, Biondi A, Travali S, McCubrey JA, Spandidos DA and
Libra M: Emerging targeted therapies for melanoma treatment
(review). Int J Oncol. 45:516–524. 2014.PubMed/NCBI
|
|
10
|
Chalkiadaki G, Nikitovic D, Katonis P,
Berdiaki A, Tsatsakis A, Kotsikogianni I, Karamanos NK and
Tzanakakis GN: Low molecular weight heparin inhibits melanoma cell
adhesion and migration through a PKCa/JNK signaling pathway
inducing actin cytoskeleton changes. Cancer Lett. 312:235–244.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamanaka K, Nakahara T, Yamauchi T, Kita
A, Takeuchi M, Kiyonaga F, Kaneko N and Sasamata M: Antitumor
activity of YM155, a selective small-molecule survivin suppressant,
alone and in combination with docetaxel in human malignant melanoma
models. Clin Cancer Res. 17:5423–5431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ribatti D: The CAM assay in the study of
angiogenesis and metastasis. The Chick Embryo Chorioallantoic
Membrane in the Study of Angiogenesis and Metastasis. Springer.
(Netherlands). 2010. View Article : Google Scholar
|
|
13
|
Murphy JB and Rous P: The behavior of
chicken sarcoma implanted in the developing embryo. J Exp Med.
15:119–132. 1912. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deryugina EI and Quigley JP: Chick embryo
chorioallantoic membrane model systems to study and visualize human
tumor cell metastasis. Histochem Cell Biol. 130:1119–1130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klingenberg M, Becker J, Eberth S, Kube D
and Wilting J: The chick chorioallantoic membrane as an in vivo
xenograft model for Burkitt lymphoma. BMC Cancer. 14:3392014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ribatti D, Nico B, Cimpean AM, Raica M,
Crivellato E, Ruggieri S and Vacca A: B16-F10 melanoma cells
contribute to the new formation of blood vessels in the chick
embryo chorioallantoic membrane through vasculogenic mimicry. Clin
Exp Med. 13:143–147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li M, Pathak RR, Lopez-Rivera E, Friedman
SL, Aguirre-Ghiso JA and Sikora AG: The In Ovo Chick
Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft
Model of Hepatocellular Carcinoma. J Vis Exp. 2015:e52411.
2015.
|
|
18
|
Comşa Ş, Popescu R, Avram Ş, Ceaușu RA,
Cîmpean AM and Raica M: Bevacizumab Modulation of the Interaction
Between the MCF-7 Cell Line and the Chick Embryo Chorioallantoic
Membrane. In Vivo. 31:199–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Workman P, Aboagye EO, Balkwill F, Balmain
A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA,
Glennie MJ, et al: Committee of the National Cancer Research
Institute: Guidelines for the welfare and use of animals in cancer
research. Br J Cancer. 102:1555–1577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ha L, Noonan FP, De Fabo EC and Merlino G:
Animal models of melanoma. J Investig Dermatol Symp Proc. 10:86–88.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Becker JC, Houben R, Schrama D, Voigt H,
Ugurel S and Reisfeld RA: Mouse models for melanoma: A personal
perspective. Exp Dermatol. 19:157–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ribatti D: The chick embryo
chorioallantoic membrane in the study of tumor angiogenesis. Rom J
Morphol Embryol. 49:131–135. 2008.PubMed/NCBI
|
|
23
|
Mena S, Rodriguez ML, Ortega A, Priego S,
Obrador E, Asensi M, Petschen I, Cerdá M, Brown BD and Estrela JM:
Glutathione and Bcl-2 targeting facilitates elimination by
chemoradiotherapy of human A375 melanoma xenografts overexpressing
bcl-xl, bcl-2, and mcl-1. J Transl Med. 10:82012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rigon RB, Oyafuso MH, Fujimura AT,
Gonçalez ML, do Prado AH, Gremião MP and Chorilli M:
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral
Therapy: A Review. BioMed Res Int. 2015:8418172015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niezgoda A, Niezgoda P and Czajkowski R:
Novel Approaches to Treatment of Advanced Melanoma: A Review on
Targeted Therapy and Immunotherapy. BioMed Res Int.
2015:8513872015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baderca F, Solovan C and Boghian L:
Epidemiological and morphological data of ocular melanocytic
lesions. Rom J Morphol Embryol. 54:77–83. 2013.PubMed/NCBI
|
|
27
|
Zurac S, Neagu M, Constantin C, Cioplea M,
Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et
al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in
cutaneous melanoma with regression and their possible function as
prognostic predictors. Oncol Lett. 11:3354–3360. 2016.PubMed/NCBI
|
|
28
|
Wang L, Hurley DG, Watkins W, Araki H,
Tamada Y, Muthukaruppan A, Ranjard L, Derkac E, Imoto S, Miyano S,
et al: Cell cycle gene networks are associated with melanoma
prognosis. PLoS One. 7:e342472012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fedorenko IV, Gibney GT and Smalley KSM:
NRAS mutant melanoma: Biological behavior and future strategies for
therapeutic management. Oncogene. 32:3009–3018. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rodrigueza WV, Woolliscroft MJ, Ebrahim
AS, Forgey R, McGovren PJ, Endert G, Wagner A, Holewa D, Aboukameel
A, Gill RD, et al: Development and antitumor activity of a BCL-2
targeted single-stranded DNA oligonucleotide. Cancer Chemother
Pharmacol. 74:151–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Russo AE, Torrisi E, Bevelacqua Y,
Perrotta R, Libra M, McCubrey JA, Spandidos DA, Stivala F and
Malaponte G: Melanoma: Molecular pathogenesis and emerging target
therapies (Review). Int J Oncol. 34:1481–1489. 2009.PubMed/NCBI
|
|
32
|
Jones V and Katiyar SK: Emerging
phytochemicals for prevention of melanoma invasion. Cancer Lett.
335:251–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ribatti D, Annese T and Longo V:
Angiogenesis and melanoma. Cancers (Basel). 2:114–132. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Streit M and Detmar M: Angiogenesis,
lymphangiogenesis, and melanoma metastasis. Oncogene. 22:3172–3179.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rozenberg GI, Monahan KB, Torrice C, Bear
JE and Sharpless NE: Metastasis in an orthotopic murine model of
melanoma is independent of RAS/RAF mutation. Melanoma Res.
20:361–371. 2010.PubMed/NCBI
|
|
36
|
Folkman J and Cotran R: Relation of
vascular proliferation to tumor growth. Int Rev Exp Pathol.
16:207–248. 1976.PubMed/NCBI
|
|
37
|
Friend JV, Crevel RW, Williams TC and
Parish WE: Immaturity of the inflammatory response of the chick
chorioallantoic membrane. Toxicol In Vitro. 4:324–326. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dupertuis YM, Delie F, Cohen M and Pichard
C: In ovo method for evaluating the effect of nutritional therapies
on tumor development, growth and vascularization. Clin Nutr Exp.
2:9–17. 2015. View Article : Google Scholar
|
|
39
|
Dehelean CA, Feflea S, Ganta S and Amiji
M: Anti-angiogenic effects of betulinic acid administered in
nanoemulsion formulation using chorioallantoic membrane assay. J
Biomed Nanotechnol. 7:317–324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dehelean CA, Feflea S, Gheorgheosu D,
Ganta S, Cimpean AM, Muntean D and Amiji MM: Anti-angiogenic and
anti-cancer evaluation of betulin nanoemulsion in chicken
chorioallantoic membrane and skin carcinoma in Balb/c mice. J
Biomed Nanotechnol. 9:577–589. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Papoutsi M, Siemeister G, Weindel K,
Tomarev SI, Kurz H, Schächtele C, Martiny-Baron G, Christ B, Marmé
D and Wilting J: Active interaction of human A375 melanoma cells
with the lymphatics in vivo. Histochem Cell Biol. 114:373–385.
2000.PubMed/NCBI
|
|
42
|
Papoutsi M, Kurz H, Schächtele C, Marmé D,
Christ B, Pröls F and Wilting J: Induction of the blood-brain
barrier marker neurothelin/HT7 in endothelial cells by a variety of
tumors in chick embryos. Histochem Cell Biol. 113:105–113. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marton A, Kúsz E, Kolozsi C, Tubak V,
Zagotto G, Buzás K, Quintieri L and Vizler C: Vanillin Analogues
o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation
and Suppress Growth of A375 Human Melanoma. Anticancer Res.
36:5743–5750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nowak-Sliwinska P, Segura T and
Iruela-Arispe ML: The chicken chorioallantoic membrane model in
biology, medicine and bioengineering. Angiogenesis. 17:779–804.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Beaumont KA, Mohana-Kumaran N and Haass
NK: Modeling Melanoma In Vitro and In Vivo. Healthcare (Basel).
2:27–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L,
Zhang Z, Cai T and Zhu Y: Variant G6PD levels promote tumor cell
proliferation or apoptosis via the STAT3/5 pathway in the human
melanoma xenograft mouse model. BMC Cancer. 13:2512013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng AW, Jia DD, Xia LM, Jin G, Wu H and
Li T: Impact of carboplatin plus paclitaxel combined with endostar
against A375 melanoma cells: An in vitro and in vivo analysis.
Biomed Pharmacother. 83:1321–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Maishi N, Ohba Y, Akiyama K, Ohga N,
Hamada J, Nagao-Kitamoto H, Alam MT, Yamamoto K, Kawamoto T, Inoue
N, et al: Tumour endothelial cells in high metastatic tumours
promote metastasis via epigenetic dysregulation of biglycan. Sci
Rep. 6:280392016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jin J, Zhang Y, Li Y, Zhang H, Li H, Yuan
X, Li X, Zhou W, Xu B, Zhang C, et al: RNA-interference-mediated
downregulation of Pin1 suppresses tumorigenicity of malignant
melanoma A375 cells. Neoplasma. 60:92–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Belizario JE: Immunodeficient Mouse
Models: An Overview. Open Immunol J. 2:79–85. 2009. View Article : Google Scholar
|
|
51
|
Envigo: Research Models and Services:
Oncology-Mutant Mice. Athymic Nude Mice. Envigo RMS Division.
(Indianapolis, IN). 2016.http://www.envigo.com/resources/data-sheets/envigo-5193-131-leaflets-2016-nude-mouse-combination-a4-refs.pdf
|
|
52
|
Herwig N, Belter B and Pietzsch J:
Extracellular S100A4 affects endothelial cell integrity and
stimulates transmigration of A375 melanoma cells. Biochem Biophys
Res Commun. 477:963–969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Clark AG and Vignjevic DM: Modes of cancer
cell invasion and the role of the microenvironment. Curr Opin Cell
Biol. 36:13–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Craft N, Bruhn KW, Nguyen BD, Prins R,
Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS and Miller JF:
Bioluminescent imaging of melanoma in live mice. J Invest Dermatol.
125:159–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gajda M and Kaminska-Winciorek G: Do not
let to be late: Overview of reasons for melanoma delayed diagnosis.
Asian Pac J Cancer Prev. 15:3873–3877. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dehelean CA, Soica C, Pinzaru I, Coricovac
D, Danciu C, Pavel I, Borcan F, Spandidos DA, Tsatsakis AM and
Baderca F: Sex differences and pathology status correlated to the
toxicity of some common carcinogens in experimental skin carcinoma.
Food Chem Toxicol. 95:149–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
